Sensei biotherapeutics presents preclinical data for sns-101, a ph-selective anti-vista antibody, at the society for immunotherapy of cancer (sitc) 36th annual meeting

V-domain ig-containing suppressor of t-cell activation (vista) is a novel immune checkpoint protein that has been recognized as an important potential immunotherapeutic target
SNSE Ratings Summary
SNSE Quant Ranking